The drug administration law has been comprehensively revised to reflect the "four latest"!

At 10 a.m., the general office of the Standing Committee of the National People's Congress held a press conference on August 26, 2019! "The drug administration law is a comprehensive overhaul 18 years later," said Yuan Jie, director of the policy and regulation department of the State Drug Administration at the meeting The drug administration law was formulated in 1984 and revised in February 2001 Except for the individual clauses that were revised in December 2013 and April 2015 due to the reform of "release of management service", there was no major revision This comprehensive revision of the drug administration law reflects the "four latest" The first is to combine drug management and people's health closely In the purpose of legislation, it is clearly stipulated to protect and promote public health As for the relationship between medicine and health, from the perspective of the concept of drug development around the world, it is constantly improving At first, our draft did not promote, only to protect public health With the deepening of the concept, medicine Quality management should not only protect but also promote public health The combination of drug administration and people's health is also reflected in Article 3, which clearly puts forward that people's health should be the center of drug administration In the whole process of drug management system design, we adhere to reflect this concept The second is to adhere to risk management, which runs through the concept of risk management in drug development, production, operation, use, post marketing management and other aspects, and adhere to social co governance The third is new We should adhere to the problem orientation in the new development period, problems in the development process of drug management, adhere to the problem orientation, respond to social concerns, and resolutely implement the principle of "four strictest" The fourth new is to give full play to the supreme authority of the law and make regulations on drug management around the improvement of drug quality system As you know, this draft was revised for the first time According to the opinions of all parties and the practical needs of the development of China's pharmaceutical industry, it was changed from the second trial to the revised draft, which comprehensively and systematically stipulated the pharmaceutical management system "